Howard Hushes Medical Institute and Departments of Phvsiology and Biochemistry, University of California, San Francisco, In the nervous system, a wide diversity of K+ channels are formed by the oligomeric assembly of subunits encoded by a large number of K+ channel genes. The physiological functions of a specific K+ channel subunit in viva will be dictated in part by its subcellular location within neurons. pressed in Xenopus oocytes. Moreover, these subunits can assemble into heteromultimeric channels with novel characteristics, thus generating a further level of diversity (Christie et al., 1990; Isacoff et al., 1990; McCormack et al., 1990; Ruppersberg et al., 1990) . Despite rapid progress in the electrophysiological characterization of cloned K+ channels, however, little is known about the specific roles played by the various K+ channel gene products in vivo. This problem is compounded by the considerable overlap in functional properties between known K+ channel genes, at least when assayed in heterologous expression systems. Toward understanding the neurobiological functions of a specific K+ channel subunit, important steps include (1) mapping the expression pattern of its mRNA in the nervous system, (2) defining the localization of the subunit protein at the subcellular level, (3) determining the molecular composition of the K+ channel complex of which it is a component, and (4) correlating the expression of the K+ channel subunit with the specific cellular conductances to which it contributes.
Such approaches have shed light on the functions of two rat K+ channel genes that likely form A-type channels in vivo: Kv 1.4, a putative presynaptic K+ channel subunit involved in control of neurotransmitter release, and Kv4.2, a dendritic K+ channel subunit potentially important in regulating postsynaptic excitability .
Kv1.2, like Kv1.4, is a member of the Shaker subfamily of voltage-gated K+ channels (Stiihmer et al., 1989; Jan and Jan, 1990; Roberds and Tamkun, 199 1) . In contrast to Kvl.4, Kv1.2 encodes a very slowly inactivating "delayed rectifier"-type K+ conductance when expressed as a homomultimer in Xenopus oocytes (Stiihmer et al., 1989) . With respect to pharmacological properties, Kv 1.2 channels exhibit a particularly high sensitivity to 4-aminopyridine (4AP) and dendrotoxin (DTX) (Stiihmer et al., 1989) , and, indeed, Kv1.2 subunits have been shown biochemically to be the major component of the DTX acceptor protein(s), purified from brain by DTX affinity chromatography (Scott et al., 1990) . In a combined in situ hybridization (ISH) and immunocytochemical analysis, we report here that the subcellular distribution of the Kv1.2 subunit varies in different neuronal cell types in rat brain. In some neurons expressing the Kvl.2 gene, the Kv1.2 protein appears predominantly in nerve terminals, while in others it is found mainly in dendrites. Based on the fact that Kvl.2 forms heteromultimers with several other K+ channel subunits, we speculate that its differential subcellular distribution could be the result of passive targeting of Kvl.2, directed by distinct subunit partners in different neurons. In this way, Kv 1.2 could participate in different heteromultimers and play diverse functional roles in different neurons in the nervous system. Materials and Methods Antibody production. Kv 1.2C antibodies were raised in rabbits against the peptide CNEDFREENLKTANCTLANT [correspondmg to residues 468-486, near the C-terminus of the predicted Kv1.2 gene product (Sttihmer et al., 1989) ] as described . Antibodies were then affinity purified by standard methods (Harlow and Lane, 1988) on an antigen column, which was made by coupling the antigenic peptide via its cvsteine residue to Sulfolink columns (Pierce. Rockford. IL).
Imm&oblot. Brain membranes were prepared as described in the presence of phenylmethylsulfonyl fluoride (1 mM), aprotinin (2 &ml), benzamidine (1 mM), leupeptin (1 &ml), and pepstatin (1 fig/ml ). Western blotting was performed as described ) using affinity-purified Kvl.ZC antibodies at l-2 &ml. Donkey anti-rabbit IgG conjugated with horse radish peroxidase (Amersham, Arlington Heights, IL) was applied at 1:5000 for 1 hr at room temperature, and visualized using enhanced chemiluminescence reagents (ECL, Amersham).
Zmmunohistochemistry. Immunohistochemistry was performed both on 10 pm cryostat sections of fresh-frozen rat brain as described , and on free-floating brain sections from rats that had been anesthetized with pentobarbital and perfused with 4% formaldehyde/ 0.1% glutaraldehyde via the transcardiac route. Sections (50 pm) were cut with a Vibratome, washed in 0.1 M Tris, pH 7.6, and treated with 1% hydrogen peroxide for 30 min. After further washing in Tris-buffered saline (TBS: 50 mM Tris, pH 7.6, 100 mM NaCl), sections were blocked for 30 min in TBS containing 0.1-0.3% Triton X-100, plus 3% normal goat serum, and 0.1% BSA. Affinity-purified Kvl.ZC antibodies were applied in the same medium at 2 &ml, overnight. Biotinylated goat anti-rabbit secondary antibodies and avidin-biotin HRP complexes (Vectastain Elite, Vector Labs, Burlingame, CA) were applied for 2 hr each, with intervening washes (3 x 15 min) in TBS containing 0.1% Triton. Antigen was visualized by incubation in diaminobenzidine (0.5 mg/ml) and hydrogen peroxide (0.01%). Overall similar results were obtained with frozen sections or free-floating perfusion-fixed sections, though the cellular architecture was better preserved with the latter method.
In situ hybridization. ISH was performed as described in detail in Tsaur et al. (1992) .
Results
Kv 1.2 mRNA is widely expressed in a distinctive pattern in the rat brain . To determine the distribution of the Kv 1.2 protein, we raised antibodies (termed Kv 1.2C) against a peptide from the C-terminal part of the polypeptide, a region that is highly divergent in amino acid sequence between known K+ channel genes. (Rehm et al., 1989; Muniz et al., 1992) , which consists predominantly of Kv 1.2 (Scott et al., 1990) . The additional band of -68 kDa is also specifically competed by the Kv1.2C peptide (Fig. lB) , but this band almost certainly does not represent a product of the Kvl.2 gene because (1) it is present in GH, cells, (2) it behaves quite differently from the 75-85 kDa polypeptides on anion-exchange chromatography (Sheng et al., 1993) , and (3) B, The 75-85 kDa band recognized by Kv 1.2C antibodies in rat whole brain (Br) is absent in rat GH, cells (GH), and is abolished by preincubation of Kv1.2C antibodies with an excess of the Kvl.2C immunogenic DeDtide (+C. 10 ue/ml Kvl.2C DeDtide: -C. no comoetitor peptide).-The additional band of -68 kDa; which is present in GH, cells and in the brain, is also specifically competed by excess Kv1.2C peptide, but it almost certainly represents an unrelated polypeptide (see Results). The immunoblot in B was exposed longer than that in A in order to show absence of specific signal in GH, cells and in competition controls; thus, the Kv1.2 band(s) is seen as more diffuse.
not copurify or coimmunoprecipitate with the related K+ channel subunit Kv 1.4, and is not immunoprecipitated by Kv 1.2C antibodies (Sheng et al., 1993) . Taken together, these results suggest that the 75-85 kDa poly-Subcellular Localization of Kvl.2
Figure 2. Kvl.2 immunoreactivity in dendrites of pyramidal and hilar neurons in hippocampus: staining pattern of affinity-purified Kv1.2C antibodies in dentate gyrus region (A), CA1 region (C), and CA3 region (E) qf the hippocampus. ISH patterns (dark-jeld illumination) of Kvl.2 mRNA are shown for the same regions in B, D, and F, respectively. DC, dentate gurus; g, granule cell layer of dentate gyrus; h, hilus of dentate gyms; p, pyramidal cell layer; sr, stratum radiatum; sl, stratum lucidum. Scale bars: A, C, and E, 0.16 mm; B, D, and F, 0.4 mm.
peptides recognized by Kvl.2C antibodies represent the products of the Kvl.2 gene, and that the 68 kDa band is a protein that cross-reacts to the Kv1.2C antibodies. This conclusion is further supported by developmental correlations with Kv1.2 mRNA expression (see Discussion). The 75-85 kDa proteins are present at roughly similar levels in cerebral cortex, hippocampus, and cerebellum ( Fig. M) , in agreement with ISH and Northern data (Beckh and Pongs, 1990) , which reveal abundant expression of Kv 1.2 mRNA in all major brain regions.
Immunohistochemical localization of Kv1.2 in rat brain
Immunohistochemical staining with affinity-purified Kvl.2C antibodies reveals widespread expression of the Kv 1.2 protein in rat forebrain and cerebellum, with immunoreactivity detected in both white matter and gray matter. The staining pattern was specific to Kv 1.2C antiserum and was abolished by competition with the immunogenic, but not an unrelated, peptide (data not shown). The subcellular localization of Kvl.2 is considered below in different parts of the brain.
Hippocampus By ISH, Kv 1.2 mRNA is concentrated in the cell body layers of the hippocampal formation, with high levels found in the pyramidal cells (CA3 > CAl), and lower levels in the granule cells of the dentate gyrus (Fig. 2B,D,F' ). In addition, numerous cells within the hilus of the dentate gyrus express Kv 1.2 mRNA abundantly (Fig. 2B ). Parallel immunostaining of hippocampal sections with Kv 1.2C antibodies reveals that Kv 1.2 protein is predominantly associated with the dendrites of pyramidal and hilar neurons ( Fig. 2A,C,E) . Significantly, the degree of immunoreactivity in the various subregions of the hippocampus correlates with Kv1.2 mRNA distribution, suggesting that the authentic Kv 1.2 polypeptide is being detected by Kv 1.2C antibodies. Thus, the dendrites of hilar neurons and of CA3 pyramidal cells are especially heavily labeled, CA 1 pyramidal cell dendrites are labeled to a lesser degree, and dentate granule cells show little dendritic immunoreactivity (Fig. 2) . The dendritic staining of pyramidal and hilar cells appears to be uniform rather than punctate, and immunoreactivity in pyramidal cell dendrites extends out into fine branches in the stratum radiatum and stratum lacunosum moleculare. The cell bodies of pyramidal neurons, however, show a conspicuous lack of immunoreactivity. Similarly, although occasional hilar neuron somata are faintly outlined, the level of staining in cell bodies is much weaker than in the dendrites of the same hilar cells ( Fig.  2A) . We have been unable to detect Kv 1.2C immunoreactivity associated with axons or terminals of pyramidal neurons, although their trajectories and terminal fields are well described in the hippocampus; relatively low levels of Kv1.2 protein at these locations, however, cannot be excluded. These results suggest that Kv1.2 protein (which is presumably translated in the cell body where its mRNA is localized) is concentrated in the dendritic compartment of hippocampal pyramidal and hilar neurons.
In contrast to hilar and pyramidal neurons, no convincing staining of dentate granule cell dendrites was found. Instead, Kv 1.2 immunoreactivity was detected as numerous large puncta along the course of the mossy fiber tract close to the CA3 pyramidal cell layer, in structures characteristic of giant mossy fiber nerve terminals (Fig. 3A,B) . These terminals correspond to en passant synapses made by the axons of dentate granule cell axons (mossy fibers) with the proximal dendrites of CA3 pyramidal cells. No immunoreactivity was detected in the mossy fiber axons, however, in contrast to Kv 1.4 . Thus, in dentate granule cells, which express relatively low levels of Kvl.2 mRNA (Fig. 2B) , Kvl.2 protein appears to be concentrated in nerve endings.
In addition to the dendritic staining in CAl, CA3, and the hilus, a well-defined band of Kv 1.2 immunoreactivity is also present, occupying the middle third of the molecular layer of the dentate gyrus and the stratum lacunosum moleculare of CA 1 (Fig. 3C ). These features of the Kvl.2 staining pattern are superimposable with that of Kv1.4, a probable presynaptic K+ channel subunit with which Kv1.2 forms heteromeric channels in vivo (Sheng et al., 1993) . The middle third of the dentate molecular layer and the stratum lacunosum moleculare receive the terminations of the medial perforant pathway projection that originates predominantly from layer II neurons of the medial entorhinal cortex (Steward and Scoville, 1976) , while the outer third ofthe molecular layer is the terminal field of the lateral perforant path originating from the lateral entorhinal cortex. Interestingly, the neurons of layer II of the medial, but not the lateral, entorhinal cortex express high levels of Kv1.2 mRNA (Fig. 30) . Taken together, these findings suggest that the band of Kv1.2C immunoreactivity in the dentate molecular layer is due to the presence of Kvl.2 subunits in the terminals of the medial perforant path axons.
Cerebellum
The selective localization of Kv 1.2 in nerve terminals is perhaps most convincingly demonstrated in the cerebellum. The most intense Kvl.2 immunoreactivity of the whole brain is found here, in the plexuses of nerve terminals that ensheathe the base and initial axon segments of Purkinje cells (Fig. 4A,B) . These plexuses [termed "pinceaus" by Palay and Chan-Palay (1974) ] are physically distinguishable from the Purkinje neuron and are uniquely characteristic of the nerve endings ofbasket cells. Consistent with this interpretation, ISH shows that Kv1.2 mRNA is abundantly expressed in numerous cell bodies in the deep half of the molecular layer of the cerebellar cortex, a distribution characteristic of basket cell somata (Palay and Chart-Palay, 1974) . No Kv 1.2 immunoreactivity could be detected in the cell bodies and major dendrites of basket cells, even after prolonged immunohistochemical development. Thus, in cerebellar basket cells, the Kvl.2 protein is predominantly, if not exclusively, localized to the nerve terminals. The high concentration of Kv 1.2 protein in a restricted compartment of a cell expressing large amounts of the mRNA could account for the extraordinary intensity of immunostaining in basket cell nerve terminals relative to that found in dendrites of hippocampal pyramidal cells and cerebellar Purkinje cells (see below).
ISH reveals that Purkinje cells also express Kv1.2 mRNA (Fig. 4C.D) . In contrast to basket cells, however, Purkinje cells show Kv1.2 immunoreactivity in their cell bodies and major dendritic branches, although at a lower density than that found in basket cell nerve endings. Purkinje cells appear to be the only neurons of the rat brain that show relatively high levels of Kvl.2 immunoreactivity in their soma. The granule cells of the cerebellar cortex express low levels of Kv1.2 mRNA (Fig. 4C,D ; Tsaur et al., 1992) and immunostaining of the granule cell layer is also close to background. A low level of diffuse Kvl.2 immunoreactivity exists in the molecular layer of the cerebellum, but the origin of this staining is unclear.
Cerebral cortex Kvl.2C antibodies stain the neuropil in all regions, and throughout the thickness, of the cerebral cortex. In addition to the general neuropil staining, a striking feature is the labeling of the major apical dendrites of pyramidal neurons: Kv 1.2 immunoreactivity appears to be present throughout the length of the apical dendrite and in its terminal branches in layer I (Fig. 5,  right) . Although Kvl.2 staining is not restricted to particular cortical layers, the most immunoreactive apical dendrites appear to arise in particular from cells in the deeper part of the cortex (layer V). This distribution correlates with ISH, which reveals Kv 1.2 hybridization throughout the cortex, with partic-Subcellular Localization of Kvl.2 ularly dense signal over large cell bodies in layer V (Fig. 5, left) . In contrast to mRNA localization, the somata of pyramidal cells (and other cortical neurons) are relatively spared of Kv 1.2 immunoreactivity and appear as "white holes" against the general neuropil staining (Fig. 5, right) .
White matter Kv 1.2 immunoreactivity is present in the corpus callosum, the large white matter tract connecting the two cerebral hemispheres (Fig. 6A) . The staining appears as numerous fibers running horizontally through the corpus callosum, though the degree of staining is not homogeneous, being more intense in the ventral portion of the corpus callosum. No immunoreactivity was found to be associated with glial cells in the corpus callosum; this is consistent with ISH, which shows an absence of cells expressing Kv1.2 mRNA in white matter tracts (Fig. 6B) . In conjunction with Kv 1.2 staining in the white matter of the internal capsule (data not shown), these findings suggest that the Kv 1.2 K+ channel subunit is present in axons of projection neurons.
Discussion

Heterogeneity of Kvl.2 polypeptides
Although partial proteolysis cannot be totally excluded, we think that the heterogeneity of the Kv 1.2 (75-85 kDa) bands detected on immunoblot is unlikely to be due to protein degradation because (1) the heterogeneity was reproducible in different membrane preparations from different rats, (2) protease inhibitors were present throughout membrane preparation, which was always performed at <4"C, and (3) the same membrane protein preparations, or even the same immunoblot, showed no evidence of proteolysis when probed with antibodies against other K+ channel or glutamate receptor subunits.
The difference in size from the predicted molecular weight of Kv1.2 (57 kDa) could be explained at least in part by posttranslational modifications such as glycosylation, which is predicted from the sequence of the protein (Sttihmer et al., 1989; Roberds and Tamkun, 1991) and suggested by the strong binding of Kv1.2 polypeptides to lectin columns (Sheng et al., 1993 glycoproteins of similar size and heterogeneity (Rehm et al., 1989; Muniz et al., 1992) . The reason for the heterogeneity of Kv 1.2 polypeptides is unknown, but it is tempting to speculate that it may be related to the differential subcellular distributions of Kv 1.2 protein. The heterogeneity cannot be accounted for solely by differential glycosylation, however, since deglycosylation reduces the molecular size, but has little effect on the degree of heterogeneity, of Kvl.2/DTX-acceptor proteins (Rehm et al., 1989; Muniz et al., 1992) .
_ , Locatlzatlon of Kv1.2 proteins Peptide antibodies directed against the C-terminal region of Kvl.2 have been used to localize this K+ channel subunit in sections of rat brain. Taken together, the immunoblot analysis, the competition controls, and the correlation between immunohistochemical and ISH findings, argue in favor of the specificity of Kv 1.2C antibodies, and suggest that the immunostaining pattern correctly reflects the localization of the Kv 1.2 protein. This conclusion is supported by the fact that the degree of Kvl.2C immunohistochemical staining increases during postnatal de-velopment, correlating with rising levels of the 75-85 kDa polypeptides (M. Sheng and L. A. Roldan, unpublished observations) , and with the increasing expression of Kv 1.2 mRNA (Beckh and Pongs, 1990) . In contrast, the 68 kDa band is present at similarly abundant levels from birth to adult. These developmental correlations suggest that Kv 1.2C is recognizing the 7% 85 kDa rather than the 68 kDa protein(s) in brain sections, and further support the idea that the 75-85 kDa bands represent products of the Kv 1.2 gene.
In addition, the overall pattern of Kv 1.2C antibody staining is similar to the pattern of DTX radioligand binding observed in rat brain sections (Pelchen-Matthews and Dolly, 1989; Awan and Dolly, 199 1) . Since Kv 1.2 subunits represent the predominant component of DTX-binding proteins in the brain (Scott et al., 1990) , this agreement lends independent support to appropriate recognition by our Kvl.2C antibodies. Nevertheless, given the heterogeneity of Kv1.2 (75-85 kDa) polypeptides on immunoblots, it should be borne in mind that the Kvl.2C antibodies may be recognizing a set of very highly related, but nonidentical, proteins in tissue sections.
Kvl.2 protein is widely expressed across the different regions of the rat brain, and like DTX-binding sites, is found in both white matter and synapse-rich areas (Pelchen-Matthews and Dolly, 1989; Awan and Dolly, 1991) . We have not examined in detail for expression in glial cells, but our results indicate that Kv 1.2 is found predominantly in neurons.
At the subcellular level, the relative distribution of Kv1.2 protein between dendrites, axons, and nerve terminals is surprisingly variable in different neurons. With the exception of Purkinje cells, Kv 1.2 immunoreactivity is relatively absent from neuronal cell bodies, where its mRNA is localized. The subcellular distribution of Kv1.2 subunits is thus complex, con- trasting with the stereotypical segregation of Kv 1.4 and Kv4.2 subunits to axonal/terminal and somatodendritic compartments, respectively .
Di~erential subcellular localization of Kv1.2 in dcflerent cell types Although Kvl.2 is found in many subcellular compartments when the whole brain is considered, this reflects a summation of individual neuronal types in which Kv 1.2 appears to be differentially distributed among distinct domains. Thus, in pyramidal neurons of the hippocampus and cortex Kv 1.2 protein is found in dendrites, whereas in cerebellar basket cells and dentate granule cells Kv 1.2 appears to be predominantly, if not exclusively, localized to the axon terminals. As an example ofanother class, Purkinje cells express Kv 1.2 in their somata as well as in major dendrites. For hippocampal pyramidal neurons and cerebellar Purkinje cells (both of which have well-described projections and terminal fields), we could not detect any immunoreactivity, suggesting Kv 1.2 localization in axons or nerve terminals, although low levels could not be excluded. These results demonstrate that certain defined cell types in rat brain differ in their subcellular distribution of Kv1.2 protein. How might this arise?
One-possibility is that targeting signals in the Kvl.2 protein are recognized differently in different neurons, resulting in sorting to distinct subcellular locations. Alternatively, Kv 1.2 is differentially modified in a cell type-specific manner, thus altering the specificity of a targeting determinant. Another possibility is that differential extracellular interactions (e.g., with matrix components or proteins on the surfaces of neighboring cells) could determine Kvl.2 subcellular localization. The hypothesis that we favor, however, is that the Kv1.2 subunit contains no (or only weak) intrinsic sorting signals, but homes passively to various subcellular domains by virtue of its association with another K+ channel subunit that is segregated in "active" fashion. The direction of Kvl.2 sorting would then be determined by the balance of "dominant partner" subunits coexpressed with Kv1.2 in a particular neuron. Consistent with this idea is the finding that Kv 1.2 protein is complexed with several other K+ channel subunits in rat brain, including Kv1.4 (Sheng et al., 1993) , Kvl.1 (Wang et al., 1993) and Kv1.3 (M. Sheng, unpublished observations) . Moreover, all of these genes show pronounced cell type-specific differences in expression, typical of K+ channel subunit genes in general (Baldwin et al., 199 1; Drewe et al., 1992; Hwang et al., 1992; Rettig et al., 1992; Tsaur et al., 1992) thereby allowing for differential heteromultimerization and targeting. Recently, the direction of sorting of the GABA receptor a 1 subunit in transfected polarized epithelia was shown to change after assembly with the p 1 subunit (Perez-Velasquez and Angelides, 1993) providing an in vitro precedent for a "passive follower" routing mechanism.
One subunit that is directly complexed with Kvl.2 in rat brain membranes is Kv1.4 (Sheng et al., 1993) a K+ channel polypeptide that is segregated to the axonal/nerve terminal compartment of expressing neurons . The localization of Kv1.2 to the terminals of the medial perforant path projection and to the terminals of the mossy fiber axons could be dictated by association with the Kv 1.4 protein, since Kvl.4 and Kv 1.2 subunits are coexpressed in the cells of origin of these axons. Varying subunit associations in different kinds ofneurons could, thus, account for the complex and diverse subcellular targeting of Kv 1.2. An implication of this idea is that the composition of Kv 1.2-containing channels would differ in different subcellular domains.
Functional implications of Kv1.2 localization The differential subcellular distribution of Kv 1.2 implies that this K+ channel subunit performs varying sets of functions in different neurons. One major subcellular location of Kv 1.2 appears to be dendritic, as illustrated by hippocampal and cortical pyramidal cells. Kv 1.2-containing K+ channels could therefore be involved in the regulation of postsynaptic excitability and integration of synaptic signals in the dendrites of these cells. In this respect, it is noteworthy that somatodendritic DTX-sensitive K+ conductances have been recorded in hippocampal pyramidal neurons (Halliwell et al., 1986) . Kv 1.2 is also found in the nerve terminals of certain cell types (e.g., basket cells, dentate granule cells, and probably medial perforant path projection neurons). Nerve terminals have a high density of voltage-gated K+ channels (Bartschat and Blaustein, 1985; Bielefeldt et al., 1992) and in this location, Kvl.2 would be well placed to regulate the duration of the presynaptic action potential and thus the amount of neurotransmitter release.
The finding of Kv1.2 in white matter tracts of brain is consistent with radioligand studies that reveal numerous DTXbinding sites in white matter areas of rat brain, including the corpus callosum (Halliwell et al., 1986; Pelchen-Matthews and Dolly, 1989; Awan and Dolly, 199 1) . That Kv 1.2 may be complexed with other K+ channel subunits that dominantly confer inactivation on the heteromeric channel cannot be excluded (e.g., Kvl.4; Sheng et al., 1993) . Nevertheless, the results suggest that Kv 1.2 channels, in the form of homomultimers or heteromultimers with other noninactivating subunits, may contribute to delayed rectifier-type K+ currents in axons. Slowly inactivating voltage-dependent K+ conductances have been described in myelinated axons (Dubois, 1983) and are central to the squid giant axon model of action potential repolarization.
Of the known Shaker-like K+ channels, Kv 1.2 is particularly sensitive to 4AP and DTX (Stiihmer et al., 1989) . Although these pharmacological features are not necessarily unique to Kv 1.2-containing K+ channels in vivo, it is, nevertheless, worth noting that DTX-sensitive and 4AP-sensitive K+ currents have been described that are consistent with immunolocalization of Kv1.2 reported here, for example, in the somatodendritic domain of hippocampal pyramidal neurons (Halliwell et al., 1986) in nerve terminals (Anderson and Harvey, 1988; Dolly, 1988; Tibbs et al., 1989; Bielefeldt et al., 1992) , and in myelinated nerve fibers (Dubois, 1983; Benoit and Dubois, 1986) . Participation of Kv 1.2 in these channels could account for their similar pharmacology, while the differences in kinetic behavior of these conductances could be explained by Kv 1.2 coassembly with different K+ channel subunits in these various locations. The future challenge will be to determine the different molecular compositions and electrophysiological characteristics of the various Kv 1.2-containing K+ channels in vivo, and to relate these differences to their specialized functions in neurons.
